GSK to bolster Shingrix supply

TGA grants temporary approval for the use of overseas-sourced Shingrix in Australia  GSK is set to supply Shingrix vaccines registered in Hong Kong to the Australian market for patients eligible for the shot under the National Immunisation Program (NIP).   In a letter sent to healthcare professionals late last month, GSK Australia executive country medical

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘A very welcome addition.’
Next Another year of free flu shots in the West